Cargando…
The Biochemical Basis of Hydroxymethylglutaryl-CoA Reductase Inhibitors as Neuroprotective Agents in Aneurysmal Subarachnoid Hemorrhage
Aneurysmal subarachnoid hemorrhage (SAH) has the highest morbidity and mortality rates of all types of stroke. Many aneurysmal SAH patients continue to suffer from significant neurological morbidity and mortality directly related to delayed cerebral ischemia. Pilot clinical studies of the use of Hyd...
Autores principales: | Wong, George Kwok Chu, Poon, Wai Sang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034087/ http://dx.doi.org/10.3390/ph3103186 |
Ejemplares similares
-
In Silico Characterization
of Withania
coagulans Bioactive Compounds as Potential Inhibitors
of Hydroxymethylglutaryl (HMG-CoA) Reductase of Mus
musculus
por: Azmi, Muhammad Bilal, et al.
Publicado: (2023) -
Circulating MicroRNAs in Delayed Cerebral Infarction After Aneurysmal Subarachnoid Hemorrhage
por: Lu, Gang, et al.
Publicado: (2017) -
Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Weiland, Judith, et al.
Publicado: (2021) -
Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunction (HARP-2) trial: study protocol for a randomized controlled trial
por: McAuley, Daniel F, et al.
Publicado: (2012) -
Cognitive domain deficits in patients with aneurysmal subarachnoid haemorrhage at 1 year
por: Wong, George Kwok Chu, et al.
Publicado: (2013)